Search results
Results from the WOW.Com Content Network
Lacosamide, sold under the brand name Vimpat among others, is a medication used for the treatment of partial-onset seizures and primary generalized tonic-clonic seizures. [2] It is used by mouth or intravenously .
It was developed by researchers at the National Institute on Drug Abuse (NIDA) of the United States National Institutes of Health (NIH). [1] The drug was of interest in the possible treatment of opioid dependence. [1] However, it was never marketed. [2] [3] Methocinnamox (MCAM), a close analogue of MCCAM, was first described in 2000.
NREPP holds an open submission period that runs November 1 through February 1. For an intervention to be eligible for a review, it must meet four minimum criteria: [7] The intervention has produced one or more positive behavioral outcomes (p ≤ .05) in mental health, mental disorders, substance abuse, or substance use disorders use among individuals, communities, or populations.
Another potential target of antiepileptic drugs is the peroxisome proliferator ... mainly based on a major article review in 2004, ... Vimpat 28 October 2008 ...
Antipsychotic abuse refers to the non-medical or inappropriate use of antipsychotic medications for purposes other than their intended therapeutic use. Antipsychotics, also known as neuroleptics, are a class of medications primarily used in treating psychiatric disorders such as schizophrenia , bipolar disorder , and certain types of depression .
Clobazam, sold under the brand names Frisium, Onfi and others, is a benzodiazepine class medication that was patented in 1968. [3] Clobazam was first synthesized in 1966 and first published in 1969.
Opioid agonist therapy (OAT) is a treatment in which prescribed opioid agonists are given to patients who live with opioid use disorder (OUD). [1] In the case of methadone maintenance treatment (MMT), methadone is used to treat dependence on heroin or other opioids, and is administered on an ongoing basis.
Oxcarbazepine is used alone or in combination with other medications for the treatment of focal (partial) seizures in adults. [3] In pediatric populations, it can be used by itself for the treatment of partial seizures for children 4 years and older, or in combination with other medications for children 2 years and older. [3]